ARCHIVES

Some Cancer Control Projects On Thin Ice As Board Eyes Funds For Others

This article is from The Cancer Letter archive.

Vol. 08 No. 05 | January 29, 1982

Download PDF Visit The Full Archive

Related Articles

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

July 26, 2013

Institute of Medicine Elects 80 New Members

October 24, 2014

Interim Analysis Suggests Paclical Can Reduce Blood Levels

August 26, 2011

Ellence Has Lower Risk Of Heart Damage, Study Finds

August 27, 2004

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003